References
- Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol. 7(3), 268–277 (2008).
- Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 31, 247–269 (2008).
- Weiner HL. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann. Neurol. 65(3), 239–248 (2009).
- van der Valk P, Amor S. Preactive lesions in multiple sclerosis. Curr. Opin. Neurol. 22(3), 207–213 (2009).
- Campbell GR, Ziabreva I, Reeve AK et al. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann. Neurol. 69(3), 481–492 (2011).
- Wilkins A, Scolding N. Protecting axons in multiple sclerosis. Mult. Scler. 14(8), 1013–1025 (2008).
- Cambron M, D’Haeseleer M, Laureys G, Clinckers R, Debruyne J, De Keyser J. White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis. J. Cereb. Blood Flow Metab. 32(3), 413–424 (2012).
- Goral J, Karavitis J, Kovacs EJ. Exposure-dependent effects of ethanol on the innate immune system. Alcohol 42(4), 237–247 (2008).
- Ellison RC, Zhang Y, McLennan CE, Rothman KJ. Exploring the relation of alcohol consumption to risk of breast cancer. Am. J. Epidemiol. 154(8), 740–747 (2001).
- Nielsen NR, Grønbaek M. Interactions between intakes of alcohol and postmenopausal hormones on risk of breast cancer. Int. J. Cancer 122(5), 1109–1113 (2008).
- Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 357(9258), 763–767 (2001).
- Pai JK, Hankinson SE, Thadhani R, Rifai N, Pischon T, Rimm EB. Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis 186(1), 113–120 (2006).
- Raum E, Gebhardt K, Buchner M, Schiltenwolf M, Brenner H. Long-term and short-term alcohol consumption and levels of C-reactive protein. Int. J. Cardiol. 121(2), 224–226 (2007).
- Romeo J, Wärnberg J, Marcos A. Drinking pattern and socio–cultural aspects on immune response: an overview. Proc. Nutr. Soc. 69(3), 341–346 (2010).
- Jonsson IM, Verdrengh M, Brisslert M et al. Ethanol prevents development of destructive arthritis. Proc. Natl Acad. Sci. USA 104(1), 258–263 (2007).
- Maxwell JR, Gowers IR, Moore DJ, Wilson AG. Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Rheumatology (Oxford) 49(11), 2140–2146 (2010).
- Lu B, Solomon DH, Costenbader KH, Keenan BT, Chibnik LB, Karlson EW. Alcohol consumption and markers of inflammation in women with preclinical rheumatoid arthritis. Arthritis Rheum. 62(12), 3554–3559 (2010).
- Nissen MJ, Gabay C, Scherer A, Finckh A; Swiss Clinical Quality Management Project in Rheumatoid Arthritis. The effect of alcohol on radiographic progression in rheumatoid arthritis. Arthritis Rheum. 62(5), 1265–1272 (2010).
- Welch KA. Neurological complications of alcohol and misuse of drugs. Pract. Neurol. 11(4), 206–219 (2011).
- Kovacs EJ, Messingham KA. Influence of alcohol and gender on immune response. Alcohol Res. Health 26(4), 257–263 (2002).
- Foster M, Zivadinov R, Weinstock-Guttman B et al. Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis. J. Neuroimmunol. 243(1–2), 61–68 (2012).
- D'hooghe MB, Haentjens P, Nagels G, De Keyser J. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. Eur. J. Neurol. 19(4), 616–624 (2012).
- Scalfari A, Neuhaus A, Daumer M, Ebers GC, Muraro PA. Age and disability accumulation in multiple sclerosis. Neurology 77(13), 1246–1252 (2011).
- Leray E, Yaouanq J, Le Page E et al. Evidence for a two-stage disability progression in multiple sclerosis. Brain 133(Pt 7), 1900–1913 (2010).
- Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126(Pt 4), 770–782 (2003).